Science and research facilities are the most specialized - and most operationally unforgiving - corner of Metro Vancouver's industrial inventory. Lab benches, cleanrooms, vivariums, GMP suites, and instrumentation bays do not slot into standard warehouse, manufacturing, or flex product without significant retrofit. Get the building wrong and operators lose months of permitting, hundreds of thousands in unanticipated capex, and credibility with funders or regulators.
This guide covers where Vancouver's life sciences and research cluster sits today, what the building specifications and lease economics actually look like, and how biotech, medtech, diagnostics, and translational research occupiers should approach site selection. It's written for founders, COOs, facility leads, and investors who need a working understanding of the asset class before they engage on a specific transaction.
Where the Cluster Sits in Metro Vancouver
Vancouver's life sciences ecosystem concentrates in four submarkets, each with a different character:
- Burnaby anchors the regional cluster. Discovery Park, Big Bend, and the Still Creek corridor host the largest concentration of biotech and biopharmaceutical tenants, with decades of cluster development and SFU adjacency. Discovery Park in particular has historically functioned as the gravitational centre - its purpose-built lab inventory rarely turns over, and incoming tenants frequently take adjacent or sub-lease space to enter the cluster.
- Vancouver-proper hosts smaller-footprint startups, diagnostics, and translational research in Mount Pleasant, False Creek Flats, and Olympic Village. Footprints here typically run 3,000 to 15,000 SF and trade at premium rents reflecting the urban context and proximity to UBC, BC Cancer, and BC Children's Hospital.
- Richmond hosts diagnostics, food and agritech-adjacent research, and YVR-adjacent logistics for cold-chain biologics. The submarket benefits from airport access for time-sensitive shipments and proximity to the cold-storage cluster that supports biological material handling.
- Surrey's Innovation Boulevard corridor near SFU Surrey and Fraser Health hosts medtech and digital health adjacency, plus growing south-of-Fraser talent infrastructure. The corridor offers newer building inventory at lower rents than Burnaby or Vancouver-proper, with a tradeoff in cluster density and proximity to research institutions.
What "Lab Space" Actually Means
Standard warehouse, manufacturing, and flex inventory cannot accommodate research operations without specific infrastructure. The technical baseline for purpose-built lab space includes:
- HVAC at 100% outside air with dedicated exhaust capacity for biological safety cabinets and fume hoods. Standard HVAC recirculates air; lab HVAC cannot, because contaminated air must be exhausted, not redistributed.
- Power capacity scaled to instrumentation and incubator load. Typical lab tenants need 400A to 2000A service depending on instrument profile. Mass spectrometry, electron microscopy, and high-density incubators stack quickly.
- Vibration-controlled slabs for SEM/TEM, atomic force microscopy, and precision instrumentation. Standard warehouse slabs transmit floor vibration that compromises imaging and measurement.
- Lab-grade plumbing including reverse osmosis / deionized water systems, lab-rated drains with neutralization, and material-compatible piping (PVDF or PTFE for high-purity applications).
- Envelope and containment readiness where CL2 or CL3 work is planned. Containment level 2 is achievable in most modern lab buildings with proper fit-out. CL3 requires negative pressure containment, HEPA-filtered exhaust, anteroom airlocks, sealed surfaces, and Health Canada / PHAC certification - purpose-built or substantial retrofit.
For GMP (Good Manufacturing Practice) production space - clinical trial material, commercial biologics, cell and gene therapy production - the requirements escalate further. GMP fit-outs include classified cleanroom zones (typically ISO 7 or ISO 8), gowning sequences, segregated materials and waste flows, validated environmental monitoring, and quality management system integration.
Lease Economics
Purpose-built lab space leases at meaningful premiums to standard industrial. As of mid-2026:
- Fitted lab space typically trades at $28 to $50+ PSF net, with operating costs $9 to $15 PSF reflecting higher HVAC and utility loads.
- Shell industrial converted to lab use trades closer to base flex pricing - $16 to $24 PSF net - but requires significant tenant capex for fit-out.
- R&D lab fit-out budgets run $80 to $200 PSF for typical wet-lab build-outs.
- GMP fit-out budgets run $300 to $600+ PSF depending on classification, equipment, and validation scope.
- Lease terms typically run 7 to 15 years to amortize landlord and tenant investment in specialty infrastructure. Shorter terms are achievable for pre-fitted space with minimal additional improvement.
- Tenant improvement allowances frequently reach $80 to $200+ PSF for full lab build-outs, structured against creditworthy tenancy, institutional sponsors, or letter-of-credit security.
Conversion Economics: Warehouse to Lab
Converting standard warehouse or flex space to lab use is possible but expensive. The conversion path runs roughly:
- HVAC overhaul. Replacing recirculating HVAC with 100% outside air, BSC exhaust, and fume hood capacity is the largest single line item - frequently $40 to $80 PSF on its own.
- Power upgrade. Service capacity, distribution, and emergency backup all scale up. Budget $20 to $40 PSF depending on existing service.
- Lab plumbing and gas distribution. RO/DI water, lab waste with neutralization, compressed air, vacuum, nitrogen, and process gases. $25 to $50 PSF.
- Fit-out: casework, fume hoods, biological safety cabinets, autoclaves, glasswash. $40 to $80 PSF depending on density and specification.
- Validation and commissioning for systems where regulated work is planned. Adds $10 to $30 PSF and 2 to 4 months to schedule.
The total budget for shell-to-lab conversion routinely runs $150 to $300+ PSF for full wet-lab build-outs, with timelines of 9 to 18 months from lease signing to occupancy. Conversion makes sense when the base building's clear height, floor loading, power proximity, and zoning all align - and when the lease term supports amortization. For specialty containment (CL3, GMP), conversion is rarely cost-effective versus purpose-built.
Operating Plan Considerations
Site selection for life sciences is rarely a pure real estate decision. The facility timeline has to align with funding milestones, clinical trial schedules, regulatory filings, and partnership commitments. A few practical considerations:
- Funding stage drives commitment. Seed and Series A operators frequently benefit from incubator and shared-lab arrangements (CDRD/adMare BioInnovations, university incubators, multi-tenant lab spaces). Series B and later-stage operators typically commit to 7 to 10 year terms with expansion options, supporting landlord investment in TI and aligning with operating plans through pivotal trials.
- Lead times are long. Pre-fitted lab space can be occupied in 60 to 120 days. Shell-to-lab conversion runs 9 to 18 months. Build-to-suit on raw inventory runs 18 to 30 months. Plan facility timing against funding events and program milestones, not the other way around.
- Talent catchment matters. Vancouver biotech draws from UBC, SFU, BCIT, BC Cancer, BC Children's, and the broader research ecosystem. Sites that compromise commute access to this talent pool face recruiting headwinds - particularly for early-stage R&D operators competing for senior scientific staff.
- Regulatory pathway constrains site selection. Operators planning clinical-stage product or commercial biologics need GMP-ready inventory or BTS with appropriate timeline. Operators on a research-only path have meaningfully more inventory to choose from and shorter lead times.
How to Approach Site Selection
The right process starts before the property tour. A practical sequence:
- Define scientific program. Containment level, instrumentation profile, headcount horizon (current and 3-year), regulatory pathway, and any specialty requirements (vivarium, ISO classifications, GMP).
- Translate to building specifications. Power, HVAC, plumbing, floor loading, vibration tolerance, clear height, and zoning all derive from the program. The specification document is the basis for filtering inventory.
- Filter the market. Public listings will surface a small fraction of the inventory that actually fits a specialty program. Off-market inventory - sub-lease space in Discovery Park, lab-capable buildings in Big Bend, conversion candidates in Mount Pleasant - typically requires landlord relationships and direct outreach.
- Underwrite the economics. Lease term, TI allowance, base rent, operating costs, capex commitment, and validation timeline all model together. The right deal balances landlord and tenant investment against operating plan certainty.
- Run due diligence. Power capacity, structural roof loading, slab condition, environmental history, and zoning compliance all matter. Specialty buildings carry specialty risk; due diligence has to match.
How I Can Help
I work exclusively in industrial real estate across Greater Vancouver, including the science and research segment. My focus is translating scientific and operational requirements into building specifications that survive due diligence, and connecting occupiers with the institutional landlords who own Burnaby and Vancouver's lab-capable inventory.
For occupiers, I support site selection, lease negotiation, and (where appropriate) build-to-suit and sale-leaseback structuring. For owners and developers with science-capable inventory, I support landlord representation and disposition advisory. NAI Commercial Vancouver's local market depth, combined with NAI Global's institutional capital relationships, provides full coverage for both sides of the table.
If you're evaluating a lab, cleanroom, or GMP requirement in Metro Vancouver - or holding science-capable inventory you're considering bringing to market - I'm reachable directly.
Samuel Brahem
Industrial Sales and Leasing
NAI Commercial Vancouver
1075 West Georgia Street, Suite 1300
Vancouver, BC V6E 3C9
Direct: 236.971.1180 · Office: 604.691.6620
Email: sbrahem@naicommercial.ca
Related pages: Science & Research Facilities (asset class) · Life Sciences & Biotech (industry) · Cold Storage · Manufacturing